Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.

World J Gastroenterol

Bo Feng, Wei Zhang, Bi-Fen Luo, Guang-Jun Song, Jian Wang, Qian Jin, Hong Qin, Lai Wei, Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing 100044, China.

Published: November 2014

AI Article Synopsis

Article Abstract

Aim: To investigate the impact of spleen operation (SO) on interferon-α (IFN-α)-based antiviral treatment in patients with hepatitis C virus (HCV)-related cirrhosis.

Methods: Studies were systematically identified by searching electronic databases including MEDLINE, Cochrane Library, Elsevier, and Embase up to September 30, 2013, and relevant clinical studies were reviewed. Sustained virological response (SVR) rate and adherence to therapy were taken as the endpoints of interest.

Results: A total of 603 patients from 16 studies were included in the systematic review. Of 372 patients who underwent SO followed by antiviral treatment, the total SVR rate was 39.5%. SVR was associated with HCV genotypes 2/3 (OR = 10.84; 95%CI: 5.47-21.47; P < 0.00001). IFN-α dose needed to be reduced in 29.4%, and IFN-α-based therapy was discontinued in 11.5% of patients. Analysis of controlled studies showed that SVRs were achieved in 34.1% of patients with SO and 31.1% of patients without SO. SO had no effect on the SVR rate in cirrhotic patients with genotype 1 HCV infection (OR = 1.28; 95%CI: 0.51-3.22; P = 0.60), but improved the SVR rate in patients with genotypes 2/3 infection, though the difference was not significant (OR = 0.36; 95%CI: 0.13-1.02; P = 0.05).

Conclusion: SO combined with IFN-α-based antiviral therapy may be suitable in cirrhotic patients with genotypes 2/3 HCV infection, but not in those with genotype 1 infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223274PMC
http://dx.doi.org/10.3748/wjg.v20.i41.15387DOI Listing

Publication Analysis

Top Keywords

svr rate
16
antiviral treatment
12
cirrhotic patients
12
genotypes 2/3
12
patients
10
spleen operation
8
ifn-α-based antiviral
8
hcv infection
8
patients genotypes
8
svr
5

Similar Publications

Objectives: To assess the efficacy and safety of locally manufactured generic sofosbuvir-based direct-acting antivirals in the treatment of Hepatitis C virus (HCV) infected patients on maintenance hemodialysis.

Patients And Methods: We have conducted a retrospective multicenter study including patients on maintenance hemodialysis, treated with sofosbuvir-based regimens between 01/01/2017 and 09/30/2021. Patients were treated for 12 or 24 weeks, with sofosbuvir 400 mg + ledipasvir 90 mg 3 times/week, or sofosbuvir 3 times/week + daclatasvir 60 mg/d, or sofosbuvir + daclatasvir in coformulation, 3 times/week.

View Article and Find Full Text PDF

Prediction of pre-eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks.

Ultrasound Obstet Gynecol

January 2025

Department of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR, China.

Objectives: To compare the maternal hemodynamic profile at 12 + 0 to 15 + 6 weeks' gestation in women who subsequently developed pre-eclampsia (PE) and those who did not, and to assess the screening performance of maternal hemodynamic parameters for PE in combination with the Fetal Medicine Foundation (FMF) triple test, including maternal factors (MF), mean arterial pressure (MAP), uterine artery pulsatility index and placental growth factor.

Methods: This was a prospective case-control study involving Chinese women with a singleton pregnancy who underwent preterm PE screening at 11 + 0 to 13 + 6 weeks' gestation using the FMF triple test, between February 2020 and February 2023. Women identified as being at high risk (≥ 1:100) for preterm PE by the FMF triple test were matched 1:1 with women identified as low risk (< 1:100) for maternal age ± 3 years, maternal weight ± 5 kg and date of screening ± 14 days.

View Article and Find Full Text PDF

Automated craniofacial biometry with 3D T2w fetal MRI.

PLOS Digit Health

December 2024

Department of Early Life Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London, United Kingdom.

Objectives: Evaluating craniofacial phenotype-genotype correlations prenatally is increasingly important; however, it is subjective and challenging with 3D ultrasound. We developed an automated label propagation pipeline using 3D motion- corrected, slice-to-volume reconstructed (SVR) fetal MRI for craniofacial measurements.

Methods: A literature review and expert consensus identified 31 craniofacial biometrics for fetal MRI.

View Article and Find Full Text PDF

Determination and visualization of moisture content in Camellia oleifera seeds rapidly based on hyperspectral imaging combined with deep learning.

Spectrochim Acta A Mol Biomol Spectrosc

December 2024

Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Nanjing Forestry University, Nanjing 210037, China; College of Mechanical and Electronic Engineering, Nanjing Forestry University, Nanjing 210037, China. Electronic address:

Moisture content (MC) is crucial for the storage, transportation, and processing of Camellia oleifera seeds. The purpose of this study was to investigate the feasibility for detecting MC in Camellia oleifera seeds using visible near-infrared hyperspectral imaging (VNIR-HSI) (374.98 ∼ 1038.

View Article and Find Full Text PDF

Dairy product requirement and the demand-supply gap of milk in Ethiopia have been increasing at an alarming rate due to various factors such as shortage of animal's feeds, feed staffs, feed costs, and poor genetic merits of the local breeds of the country. This problem can be lessened by selecting best breed and modern animal breeding facilities, which require technologies like big data analysis and machine learning. In this study, a prediction model that can predict age at first calving of weaned calves based on their pre-weaning and weaning parameters, including dam's parity number, season of calving, birth weight, pre-weaning health status, pre-weaning average daily weight gain (ADG), weaning age and weaning weight is developed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!